| Application no. and date | 13795002.8 (espacenet) (Federated) (European Patent Register), 20131111 | | Patent/reg. no. and date | DK/EP 2917232, 20170301 | | Publication date | 20150916 | | Priority no. and date | GB 201220328, 20121112, GB 201316660, 20130919 | | EP pub. no. and date |
EP 2917232 20150916 | | Effective date | | | Applicant/owner | Worg Pharmaceuticals (Zhejiang) Co., Ltd., Room 215, Building 2
198 Bandaozhonglu Road
Dipu Street
Anji County
Huzhou, Zhejiang, CN | | Applicant ref. no. | | | Inventor | WRAITH, David, c/o School of Cellular and Molecular Medicine
University of Bristol
Medical Sciences Building
Bristol BS8 1TD, GB,
STREETER, Heather, c/o School of Cellular and Molecular Medicine
University of Bristol
Medical Sciences Building
Bristol BS8 1TD, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 38/37 (2006.01) , A61K 39/00 (2006.01) , C07K 14/755 (2006.01) | | Title | FAKTOR VIII-AFLEDTE PEPTIDER TIL ANVENDELSE TIL BEHANDLING AF HÆMOFILI A | | Int. application no. | IB2013060060 | | Int. publication no. | WO2014072958 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
